https://www.selleckchem.com/pr....oducts/nf-kb-activat
28, P=.035) and heart failure hospitalizations (adjusted hazard ratio 1.29, P=.006). Quantitative assessment of myocardial radiotracer activity with CPA or VOI have high diagnostic accuracy for ATTR-CM. Both measures are potential non-invasive markers to follow progression of disease or response to therapy. Quantitative assessment of myocardial radiotracer activity with CPA or VOI have high diagnostic accuracy for ATTR-CM. Both measures are potential non-invasive markers to follow progression of disease or response to therapy.
Like
Comment
Share
